Apollo Hospitals Enterprise Ltd will acquire a 31% stake in Apollo Health and Lifestyle Ltd (AHLL) held by the International Finance Corporation for ₹1,254.07 crore.
The acquisition involves over 41.65 crore equity shares, making AHLL a 100% subsidiary of AHEL, with 99.42% held by AHEL and the rest in the ESOP pool.
The move aims to consolidate ownership, gain full operational control, and better integrate AHLL with Apollo’s diagnostic services.
Healthcare chain Apollo Hospitals Entreprise Ltd on Friday said it will acquire 31% stake held by International Finance Corporation in its arm Apollo Health and Lifestyle Ltd for ₹1,254.07 crore.
The company's board at its meeting held on Friday, approved execution of definitive share purchase agreements for the acquisition of a little over 41.65 crore equity shares aggregating to a 30.58% equity stake held jointly by the International Finance Corporation, Washington (IFC) and IFC EAF Apollo Investment Company (IFC EAF) in Apollo Health and Lifestyle Ltd (AHLL), Apollo Hospitals Entreprise Ltd (AHEL) said in a regulatory filing.
The board has also approved setting up a comprehensive oncology facility at Gurugram at an investment of ₹573 crore, it added.
Upon completion of the proposed acquisition of shares, AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool.
The object of the acquisition is to consolidate ownership and have full control over AHLL's operations, enabling better integration with the company's diagnostic services and improving operational efficiencies, the filing said.
"This acquisition is a decisive step that will allow for sharper capital allocation and a greater focus on select high-potential segments. With disciplined growth, improved profitability, and enhanced return on capital employed (ROCE), we see AHLL becoming a value-accretive driver in Apollo's integrated healthcare portfolio," AHEL Managing Director Suneeta Reddy said.
AHEL Joint Managing Director Sangita Reddy said IFC has been a valuable partner providing patient capital and facilitated the growth of AHLL.
"By bringing AHLL fully into Apollo's fold, we are sharpening the business focus across its four verticals-primary care and diagnostics, birthing and women's health, ambulatory care, and dialysis and dental. This sharper focus will enable AHLL to scale more effectively, innovate faster, and serve patients with care models that are more personalised, accessible, and future-ready," she added.
On the proposed comprehensive oncology centre, Apollo Hospitals Entreprise said it would enable an additional 350 patients being treated per annum, which is expected to be added by FY 2029.
